This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
Apotea AB
Q12025
5/8/2025
Sara Ahlström
COO and Deputy CEO
Good morning everyone and welcome to the presentation of Apothea's first quarter report. We are presenting here today from our office in Stockholm. We will start with a quite short presentation and the business update and then we will move on to a Q&A with spoken questions. Today's presenters will be Per Svadsson, our CEO and co-founder, Johan Morild, our CFO, and myself, Sara Ahlström, COO and Deputy CEO. And we will start by highlighting some quarterly highlights.
Per Svadsson
CEO and Co-founder
Thank you. We have had a good quarter. We have had improved profitability and stable growth. Johan, let's look at the figures.
Johan Morild
CFO
Yes, we had revenues of 1 billion 754 million in the quarter and a solid growth of 15.2%. We increased the EBIT margin from 4.1% Q1 2024 to 5.3% first quarter.
You're reading a preview of the APOTEA.ST Q1 2025 earnings call.
Free account.
Disclaimer